Analgesia Nociception Index (ANI) After Unilateral Radical Mastectomy as an Evaluation of Paravertebral Block Failure
ANIBPV
1 other identifier
observational
100
1 country
1
Brief Summary
Paravertebral Block (PVB) combined with general anesthesia (GA) is a conventional pain treatment for breast surgery but sometimes failures can occurs. The efficacy of this block has to be evaluated. Also, for the intra-operative analgesic evaluation of this block, it is necessary to measure intra-operative analgesia index. A monitor of nociception for patients under GA, the PhysiodolorisTM device, offers an index for measuring nociceptive inputs during surgery in anesthetized patients : the ANI index (based on the single R-R interval analysis). The purpose of this observational and prospective study is to assess the variations of this ANI index during breast surgery with or without axillary node dissection with a PVB. This will allow us to quantify the analgesic effect of a PVB during GA for unilateral radical breast surgery with or without axillary node dissection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 30, 2019
CompletedFirst Posted
Study publicly available on registry
February 6, 2019
CompletedStudy Start
First participant enrolled
May 2, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 26, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2023
CompletedJanuary 2, 2026
December 1, 2025
1.2 years
January 30, 2019
December 29, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Assessment of the ANI index
Assessment of the area under the curve of the variation of the ANI index for the first minute of the surgical incision according to the PVB failure: incomplete or ineffective vs effective. The PVB failure will be evaluate with a cold test on the thoracic levels T2 and T6.
first minute of the surgical incision
Secondary Outcomes (2)
Post Anesthesia Care Unit total dose of morphine will be compare according to the PVB failure or not groups.
Just after surgery (day 0)
Evaluation of pain
Just after surgery (day 0) and the day after surgery (day 1)
Interventions
A monitor of nociception for patients under general anesthesia
Eligibility Criteria
women undergo for a breast surgery with or without axillary node dissection
You may qualify if:
- American Society of Anesthesiologists score (ASA) I or II
- Woman
- Patients aged over 18 years
- BMI between 17 and 30 kg/m2
- Radical mastectomy with or without axillary node dissection.
You may not qualify if:
- Preoperative consumption of opioid
- Local Anesthesia allergy
- Local skin inflammation at the puncture area
- Inability to respond to pain assessment using a Numerical Rating Score (NRS)
- Any contra-indication or patient's refusal for regional anesthesia B blocker medication
- Pace maker
- Inability to perform the PVB (at the appreciation of the anesthesiologist)
- Change of surgical procedure other modified radical mastectomy with or without axillary node dissection.
- Patient with a severe side effect or who cannot be controlled by additional therapy will be removed from the trial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institut de Cancérologie de Lorraine (ICL)
Vandœuvre-lès-Nancy, France
Related Publications (1)
Raft J, Lamotte AS, Schohn CH, Fritz C, Richebe P. Analgesia nociception index as a tool to assess the effectiveness of paravertebral block in total mastectomy: a prospective cohort study. Braz J Anesthesiol. 2026 Jan-Feb;76(1):844699. doi: 10.1016/j.bjane.2025.844699. Epub 2025 Nov 7.
PMID: 41207559RESULT
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
RAFT JULIEN, MD
Institut de Cancérologie de Lorraine (ICL)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 26 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 30, 2019
First Posted
February 6, 2019
Study Start
May 2, 2019
Primary Completion
June 26, 2020
Study Completion
March 1, 2023
Last Updated
January 2, 2026
Record last verified: 2025-12